This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
(iii) Most importantly, TMAO may be just one of many factors that influence atherosclerosis and its complications
This makes it a useful compound for research on therapies for growth hormone deficiency and its effect on bone density
It predominantly affects women and AFAB individuals.23 Traction alopecia There are numerous other forms of hair loss outside of the primary types recognized by the AAD, many of which are temporary or rare:26 Telogen effluvium: when a large proportion of your hair follicles enter telogen, the resting phase of the hair cycle (usually temporary) Anagen effluvium: hair loss secondary to medical treatments such as chemotherapy (typically resolves after treatment ends) Tinea capitis: hair loss via fungal infection (treatable) Lichen planopilaris: hair loss that occurs when an inflammatory skin disorder called lichen planus affects the scalp (treatable and often self-resolves within 1-2 years)27 Discoid lupus erythematosus: a form of lupus (an autoimmune disease) that affects the skin and of which hair loss is a symptom Folliculitis decalvans: an inflammatory disorder that destroys hair follicles Dissecting cellulitis: a rare skin condition that causes pus-filled lumps to develop on the scalp, destroying hair follicles Loose anagen syndrome: a condition in which the hair is only loosely rooted within the follicles Trichotillomania: a mental health disorder marked by a compulsion to pull out one's hair Hypotrichosis: a genetic condition marked by sparse hair growth on both the scalp and the body How do hair growth supplements work
Tesamorelin specifically targets visceral adipose tissue, potentially addressing areas that respond less readily to general weight loss approaches
China: Demand for GLP-1 receptor agonists in China is projected to rise at 7.1% CAGR through 2036
